Johnson & Johnson’s string of talc wins has come to an end as a judge in Missouri upheld a $110 million verdict against the company. What’s more, the decision could signal trouble ahead for the drugmaker as the judge ruled
read moreWednesday, multiple myeloma medication Darzalex hit a development milestone, triggering a $20 million payment from Johnson & Johnson for Genmab. But the way one analyst sees it, the Big Pharma may eventually tire of shelling out payments and take matters
read moreAs a federal investigation into pharma’s ties with patient assistance charities spreads to some of the biggest names in the drug business, a major charity is taking heat from U.S. officials and may shutter. More: Major charity under fire for
read moreThere is no near-term relief in sight for generics makers, with erosion in the double digits to be expected next year. The key to overcoming a weak market? Complex generics and biosimilars, for those who have them, but even there success
read moreGerman regulators have signed off on a corrective and preventive action plan for one of Dr. Reddy’s formulation production facilities in India, allowing the company to market drugs manufactured at the site for the European Union. More: German regulators OK
read moreViiV Healthcare has initiated a Phase III study exploring the efficacy of long-acting cabotegravir for the prevention of HIV infection in sexually active women. More: ViiV trials drug for HIV prevention in women Source: News
read more© 1994 - 2025 B.M. Pharmaceuticals